Tags: Psychogenics

announcements

PsychoGenics and the ADDF Announce a Risk-Sharing Partnership for Preclinical Studies

We are partnering with PsychoGenics Inc. to bring its services to our grantees working on preclinical Alzheimer’s drug discovery programs.